Who owns DNTH?
Institutional ownership of Dianthus Therapeutics Inc. from Form 13F, Q2 2026
269 institutional managers reported holding Dianthus Therapeutics Inc. (DNTH) in Form 13F filings for Q2 2026, with 66,035,301 shares worth $6.4B. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 1,686,800 shares (+2.6%). 57 opened new positions and 32 sold out.
- Funds holding
- 269
- Value held
- $6.4B
- New / sold out
- 57 / 32
- Net shares, same filers
- +2.6%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of DNTH
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| FMR LLC | $799M | 12.4% | 8,199,893 | Added |
| BlackRock, Inc. | $402M | 6.2% | 4,123,822 | Added |
| T. Rowe Price Investment Management, Inc. | $379M | 5.9% | 3,888,456 | Added |
| Wellington Management Group LLP | $315M | 4.9% | 3,229,882 | Added |
| Fairmount Funds Management LLC | $247M | 3.8% | 2,537,191 | Unchanged |
| Price T Rowe Associates Inc | $245M | 3.8% | 2,514,946 | Added |
| State Street Corp | $230M | 3.6% | 2,357,440 | Added |
| Vanguard Capital Management LLC | $211M | 3.3% | 2,159,568 | Added |
| Avidity Partners Management LP | $205M | 3.2% | 2,104,184 | Trimmed |
| Octagon Capital Advisors LP | $180M | 2.8% | 1,841,667 | Trimmed |
| TCG Crossover Management, LLC | $163M | 2.5% | 1,676,624 | Unchanged |
| Fred Alger Management, LLC | $127M | 2.0% | 1,302,493 | Added |
| Geode Capital Management, LLC | $123M | 1.9% | 1,258,502 | Added |
| Venrock Adviser, LLC | $115M | 1.8% | 1,180,000 | Unchanged |
| UBS Group AG | $111M | 1.7% | 1,140,260 | Added |
| Deerfield Management Company, L.p. | $110M | 1.7% | 1,125,313 | Added |
| Jennison Associates LLC | $99.6M | 1.5% | 1,021,763 | Added |
| Polar Capital Holdings Plc | $99.3M | 1.5% | 1,018,726 | Trimmed |
| Citadel Advisors LLC | $95.0M | 1.5% | 974,911 | Trimmed |
| Franklin Resources Inc | $94.5M | 1.5% | 968,983 | Unchanged |
| Baker Bros. Advisors LP | $83.1M | 1.3% | 852,164 | Unchanged |
| Logos Global Management LP | $78.0M | 1.2% | 800,000 | Added |
| Cormorant Asset Management, LP | $73.1M | 1.1% | 750,000 | Trimmed |
| Alliancebernstein L.p. | $70.0M | 1.3% | 834,150 | Trimmed |
| Braidwell LP | $58.0M | 0.9% | 594,562 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 66,035,301 DNTH shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- T. Rowe Price Investment Management, Inc. Added+$253M
- Price T Rowe Associates Inc Added+$133M
- State Street Corp Added+$93.4M
- BlackRock, Inc. Added+$92.4M
- Wellington Management Group LLP Added+$61.8M
- Assenagon Asset Management S.A. New+$54.7M
- Jennison Associates LLC Added+$52.3M
- FMR LLC Added+$42.1M
- Logos Global Management LP Added+$39.0M
- UBS Group AG Added+$35.0M
Biggest sellers in Q2 2026
- Ra Capital Management, L.p. Sold out-$219M
- Avidity Partners Management LP Trimmed-$205M
- Farallon Capital Management, L.l.c. Sold out-$70.2M
- Citadel Advisors LLC Trimmed-$62.0M
- Point72 Asset Management, L.P. Sold out-$54.0M
- Catalio Capital Management, LP Trimmed-$51.4M
- Balyasny Asset Management L.P. Trimmed-$30.4M
- Sio Capital Management, LLC Trimmed-$30.3M
- Braidwell LP Trimmed-$29.7M
- Silverarc Capital Management, LLC Trimmed-$25.8M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $1.4B and sold $1.1B; 115 added and 69 trimmed.
Schedule 13D and 13G filings on DNTH
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-08-13WELLINGTON MANAGEMENT GROUP LLP SCHEDULE 13G filed by Dianthus Therapeutics Inc.Schedule 13G
- 2026-04-27BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2025-11-12WELLINGTON MANAGEMENT GROUP LLP SCHEDULE 13G filed by Dianthus Therapeutics Inc.Schedule 13G
- 2025-09-12Point72 Asset Management, L.P. SCHEDULE 13G filed by Dianthus Therapeutics Inc.Schedule 13G
- 2025-04-17Point72 Asset Management, L.P. SCHEDULE 13G filed by Dianthus Therapeutics Inc.Schedule 13G
Questions about DNTH ownership
- Who owns DNTH stock?
- 269 institutional investment managers reported DNTH positions in their Form 13F filings for Q2 2026, holding 66,035,301 shares worth $6.4B in total. FMR LLC reported the largest position.
- Are funds buying or selling DNTH?
- In Q2 2026, 57 managers opened new DNTH positions, 115 added, 69 trimmed and 32 sold out. Managers that filed in both quarters added a net 1,686,800 shares.
- How current is this DNTH institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to DNTH by CUSIP. Options are left out. DNTH news and filings · DNTH insider trades · Top funds